Blepharophimosis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Blepharophimosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Blepharophimosis Local Doctors?
Elite in Blepharophimosis
Elite in Blepharophimosis
Referral may be required
Gent, VLG, BE 

Elfride De Baere practices practicing medicine in Gent, Belgium. De Baere is rated as an Elite expert by MediFind in the treatment of Blepharophimosis. They are also highly rated in 20 other conditions, according to our data. Their clinical expertise encompasses Blepharophimosis, Leber Congenital Amaurosis, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Elite in Blepharophimosis
Elite in Blepharophimosis
Referral may be required
Gent, VLG, BE 

Hannah Verdin practices practicing medicine in Gent, Belgium. Ms. Verdin is rated as an Elite expert by MediFind in the treatment of Blepharophimosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Blepharophimosis, Congenital Microcoria, Sertoli Cell-Only Syndrome, Vitrectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Blepharophimosis
Elite in Blepharophimosis
Referral may be required
China's Western Technological Innovation Harbor, 
Xi'an, CN 

Mingyue Zhao practices practicing medicine in Xi'an, China. Zhao is rated as an Elite expert by MediFind in the treatment of Blepharophimosis. They are also highly rated in 3 other conditions, according to our data. Their clinical expertise encompasses Blepharophimosis Syndrome, Blepharophimosis, Ptosis, Cerebral Hypoxia, and Craniectomy.

What are the latest Blepharophimosis Clinical Trials?
A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) Used Twice Daily (BID) in the Treatment of Acquired Blepharoptosis

Summary: A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID) in the Treatment of Acquired Blepharoptosis

Match to trials
Find the right clinical trials for you in under a minute
Get started